Clinical Trial Update: Aripiprazole to Reduce Cocaine Relapse [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating aripiprazole to reduce relapse in cocaine use disorder. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cocaine Use Disorder

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)

Snippet

Sponsor: Craig Rush | Conditions: Cocaine-Related Disorders | Phase 1 | Status: COMPLETED